Rodríguez-Patiño G, Mercadillo-Pérez P

Language: Spanish
References: 19
Page: 20-25
PDF size: 298.58 Kb.

ABSTRACT

The perforating dermatosis are a group of diseases characterized by transepidermal elimination of collagen or elastic fibers, cellular detritus, keratin and/or inflammatory cells without any trigger factor. Purpose: To determine the prevalence of primary perforating dermatosis in Hospital General de Mexico of the Dermatopathology Service. Methods: Observational, retrospective and descriptive study. Review of the file and histological slides was made in Hospital General de Mexico of the Dermatophatology Service on a period of time of 30 years, including all the cases of primary perforating dermatosis. Results: The total of histopathological reports compatible with perforating dermatosis was of 22. The prevalence in Hospital General de Mexico in the Dermatopathology Service was 0.0004. The entity most frequent was perforating folliculitis, predominating in women of fourth decade of life. The clinical pathological correlation showed a concordance 0.25. Conclusions: The perforating dermatosis are a rare group of diseases which clinical diagnostic always must be accompanied of histopathological study. The biopsy is the gold standard for the diagnostic of perforating disease. It is important to make an adequate clinical-pathological correlation to treat well this cases.

REFERENCES

1. Patterson JW. The perforating disorders. J Am Acad Dermatol 1984; 10: 561-581.

2. Sehgal VN, Jain S, Thappa DM, Bhattacharya SN, Logani K. Perforating dermatoses: A review and report of four cases. J Dermatol 1993; 20: 329-340.

3. Cochran RJ, Tucker SB, Wilkin JK. Reactive perforating collagenosis of diabetes mellitus and renal failure. Cutis 1983; 31: 55-58.

4. Torres LV, Camacho FM, Mihm MC, Sober A, Sánchez CI. Dermatología Práctica Ibero-Latinoamericana Atlas, Enfermedades Sistémicas Asociadas y Terapéutica. Nieto Editores; 2005: 1093-1103.

5. Santamaría VG, Cervantes AMA, Barrios EG. Dermatosis con eliminación transepidérmica clásicas. Rev Cent Dermatol Pascua 2002; 11: 40-49.

6. Morton CA, Henderson IS, Jones MC. Acquired perforating dermatosis in a British dialysis population. Br J Dermatol 1996; 135: 671-677.

7. Bardach H. Dermatoses with transepithelial perforation. Arch Dermatol Res 1976; 257: 213-226.

8. Flannigan SA, Tucker SB, Rapini RP. Recurrent hyperkeratotic papules following superficial trauma. Reactive perforating collagenosis (RPC). Arch Dermatol 1985; 121: 1554-1558

9. Kretzschmar L, Hamm H, John SM, Brocker EB. Elastosis perforans serpiginosa. Considerations on the pathogenesis based on a typical case. Hautarzt 1992; 43: 640-644.

10. Woo TY, Rasmussen JE. Disorders of transepidermal elimination. Part 1. Int J Dermatol 1985; 24: 267-279.

11. Herzinger T, Schirren CG, Sander CA, Jansen T, Kind P. Reactive perforating collagenosis—transepidermal elimination of type IV collagen. Clin Exp Dermatol 1996; 21: 279-282.

12. Morgan MB, Truitt CA, Taira J. Fibronectin and the extracellular matrix in the perforating disorders in the skin. Am J Dermatopathol 1998; 20: 147-154.

13. Haftek M, Euvrard S, Kanitakis J. Acquired perforating dermatosis of diabetes mellitus and renal failure: Further ultrastructural clues to it’s pathogenesis. J Cutan Pathol 1993; 20: 350-355.

14. Kato N. Acquired perforating dermatosis. J Dermatol 1990; 17: 493-499.

15. Morton CA, Henderson IS, Jones MC. Acquired perforating dermatosis in a British dialysis population. Br J Dermatol 1996; 135: 671-677.

16. Mehregan AH. Perforating dermatosis: A clinicopathological review. Int J Dermatol 1977; 16: 19-27.

17. Antunes S, Mota M. Colagenosis perforante reactiva asociada a insuficiencia renal crónica y diabetes mellitus. Med Cut ILA 1988; 26: 413-416.

18. Briggs P, Fraga S. Reactive perforating collagenosis of diabetes mellitus. J Am Acad Dermatol 1995; 32: 521-3.

19. Buckhart CG. Perforating folliculitis. Int J Dermatol 1981; 20: 597-599.